pCenter for Innovative Care in Aging, Johns Hopkins University, Baltimore, MA, USA qDepartment of Psychiatry and Behavioral Sciences, Johns Hopkins University, Baltimore, MA, USA rDepartment of ...

For each adult aged ≥40 years receiving statins for the primary prevention of cardiovascular diseases, one nonuser was randomly selected and matched for year of birth, sex, residence area, and ...

Lifestyle change, weight reduction, and cardioprotective therapeutics are vital tools in primary and secondary prevention of CVD. Since the “Update on Prevention of CVD in Adults With Type 2 Diabetes ...

ACT-EARLY is the first ever primary prevention study for ATTR, testing the hypothesis that prophylactic treatment of asymptomatic carriers of a pathogenic TTR variant with the near-complete TTR ...

Participants were randomised 1:1 to receive either the haemostatic powder or no further therapy (control group). The primary outcome was the rebleeding rate within 72 hours post-treatment. Secondary ...